News Focus
News Focus
Post# of 257251
Next 10
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 121051

Wednesday, 06/22/2011 6:10:53 AM

Wednesday, June 22, 2011 6:10:53 AM

Post# of 257251
Endotis starts phase-2a trial of reversible anticoagulant for open-heart surgery:

http://finance.yahoo.com/news/Endotis-Intiates-Phase-IIa-bw-868822504.html?x=0&.v=1

Data will be available by the end of 2011. Endotis is a private biotech company based in Paris.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now